MacroGenics
MGNX
142 hedge funds and large institutions have $595M invested in MacroGenics in 2023 Q4 according to their latest regulatory filings, with 32 funds opening new positions, 45 increasing their positions, 49 reducing their positions, and 16 closing their positions.
235% more call options, than puts
Call options by funds: $295K | Put options by funds: $88K
120% more capital invested
Capital invested by funds: $270M → $595M (+$325M)
100% more first-time investments, than exits
New positions opened: 32 | Existing positions closed: 16
13% more funds holding
Funds holding: 126 → 142 (+16)
6.04% more ownership
Funds ownership: 93.68% → 99.72% (+6%)
8% less repeat investments, than reductions
Existing positions increased: 45 | Existing positions reduced: 49
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$25.7M |
| 2 |
State Street
Boston,
Massachusetts
|
+$6.04M |
| 3 |
PA
Perceptive Advisors
New York
|
+$4.23M |
| 4 |
FLSM
Frazier Life Sciences Management
Palo Alto,
California
|
+$4.14M |
| 5 |
IHAM
Integral Health Asset Management
New York
|
+$3.11M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$8.13M |
| 2 |
Nuveen
Charlotte,
North Carolina
|
-$2.27M |
| 3 |
Acadian Asset Management
Boston,
Massachusetts
|
-$2.17M |
| 4 |
Jacobs Levy Equity Management
Florham Park,
New Jersey
|
-$1.97M |
| 5 |
SAM
Sectoral Asset Management
Montreal,
Quebec, Canada
|
-$1.8M |
MGNX Hedge Fund Activity: Q4 2023 in Review
142 of the 6,869 institutional investors tracked by Wall St. Rank reported a position in MacroGenics (MGNX) for Q4 2023, worth a combined $595M — up 120% from $270M a quarter earlier.
Buyers outnumbered sellers: 32 funds opened new MGNX positions and 16 closed out — a net gain of 16 holders — while 45 added to existing stakes and 49 trimmed.
The largest buyer was RA Capital Management, adding an estimated $25.7M. The largest seller was Millennium Management, cutting an estimated $8.13M.
- 142 institutional investors held MacroGenics (MGNX) as of Q4 2023, up from 126 in Q3 2023.
- Funds reported $595M of MacroGenics stock for Q4 2023, up 120% quarter-over-quarter.
- 32 funds opened new MacroGenics positions in Q4 2023 and 16 closed out, a net change of +16 holders.
- The largest MacroGenics buyer in Q4 2023 was RA Capital Management, an estimated $25.7M added.
- The largest MacroGenics seller in Q4 2023 was Millennium Management, an estimated $8.13M sold.
Based on aggregated 13F filings for Q4 2023.